UAB 1017/TBCRC 008:A Multi-Institutional Double-Blind Phase II Study Evaluating Response and Surrogate Biomarkers to Carboplatin and Nab-Paclitaxel (CP) With or Without Vorinostat as Preoperative Chemotherapy in Her2-Negative Primary Operable Breast Cancer

Grant

Date/time Interval

  • March 22, 2011 - December 12, 2012
  • Total Award Amount

  • 34520.00
  • Direct Costs

  • 27397.00
  • Sponsor Award Id

  • SKCCC J0785
  • Contributor

  • Carpenter, John   Principal Investigator